Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Back to researchers

Peter J. Rosen

127

Works

4,227

Citations

34

h-index

63

i10-index

Research Topics

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Multiple Myeloma Research and Treatments

Affiliations

Southern Research Institute1970–1970

University of Southern California1973–1992

University of Maryland, Baltimore2009–2009

Cedars-Sinai Medical Center1993–1994

Translational Genomics Research Institute2010–2010

Top Works

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Daniel D. Von Hoff,Joseph J. Stephenson,et al.

2010632 citations

Peter J. Rosen | Researchclopedia

Cancer Treatment and Pharmacology

Protein Degradation and Inhibitors

An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

Ravi Vij,Michael Wang,et al.

2012254 citations

Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer

Howard I. Scher,Xiaoyu Jia,et al.

2011248 citations

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Mitesh J. Borad,Shantan Reddy,et al.

2014188 citations

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea

Srđan Verstovšek,Francesco Passamonti,et al.

2013174 citations

Failure of Methylene Blue Treatment in Toxic Methemoglobinemia

Peter J. Rosen,Cage S. Johnson,et al.

1971153 citations

A Phase I Single-Agent Study of Twice-Weekly Consecutive-Day Dosing of the Proteasome Inhibitor Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma or Lymphoma

Melissa Alsina,Suzanne Trudel,et al.

2012143 citations

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

Nathan Fowler,Brad S. Kahl,et al.

2011108 citations

Lymphocyte-Depletion Hodgkin's Disease

Richard S. Neiman,Peter J. Rosen,et al.

1973107 citations